Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 19% ± 4% |
Insufficient scRNA-seq data for expression of TEAD4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 1018.89 | 1805 / 1809 | 99% | 36.89 | 469 / 472 |
pancreas | 100% | 1990.25 | 328 / 328 | 97% | 25.95 | 173 / 178 |
uterus | 98% | 716.06 | 167 / 170 | 98% | 42.41 | 452 / 459 |
breast | 100% | 877.10 | 459 / 459 | 97% | 28.11 | 1081 / 1118 |
lung | 100% | 1840.32 | 577 / 578 | 96% | 26.92 | 1114 / 1155 |
thymus | 100% | 1801.96 | 653 / 653 | 93% | 16.05 | 564 / 605 |
kidney | 99% | 1096.82 | 88 / 89 | 92% | 24.75 | 829 / 901 |
esophagus | 92% | 584.39 | 1330 / 1445 | 98% | 38.19 | 179 / 183 |
intestine | 81% | 457.00 | 783 / 966 | 99% | 43.21 | 522 / 527 |
prostate | 90% | 618.44 | 221 / 245 | 82% | 10.53 | 411 / 502 |
stomach | 68% | 435.72 | 244 / 359 | 100% | 41.13 | 286 / 286 |
bladder | 71% | 799.48 | 15 / 21 | 83% | 27.88 | 416 / 504 |
ovary | 52% | 246.44 | 94 / 180 | 100% | 43.68 | 430 / 430 |
adrenal gland | 67% | 286.41 | 173 / 258 | 37% | 5.09 | 85 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 37.58 | 80 / 80 |
muscle | 100% | 4953.76 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 36.47 | 45 / 45 |
adipose | 100% | 938.36 | 1199 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 630.04 | 238 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 708.26 | 1300 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 788.46 | 827 / 861 | 0% | 0 | 0 / 0 |
liver | 25% | 133.63 | 57 / 226 | 42% | 7.98 | 172 / 406 |
brain | 23% | 86.75 | 613 / 2642 | 39% | 7.84 | 277 / 705 |
lymph node | 0% | 0 | 0 / 0 | 41% | 4.34 | 12 / 29 |
peripheral blood | 10% | 44.45 | 92 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048568 | Biological process | embryonic organ development |
GO_0001708 | Biological process | cell fate specification |
GO_0001830 | Biological process | trophectodermal cell fate commitment |
GO_0035329 | Biological process | hippo signaling |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0006351 | Biological process | DNA-templated transcription |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0007517 | Biological process | muscle organ development |
GO_0001501 | Biological process | skeletal system development |
GO_0007566 | Biological process | embryo implantation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TEAD4 |
Protein name | Transcriptional enhancer factor TEF-3 (TEA domain family member 4) (TEAD-4) (Transcription factor 13-like 1) (Transcription factor RTEF-1) TEA domain family member 4 isoform 1 (TEA domain family member 4, isoform CRA_b) TEA domain family member 4 isoform 2 Transcriptional enhancer factor TEF-3 TEA domain family member 4 isoform 1 variant (Transcriptional enhancer factor TEF-3) TEA domain transcription factor 4 TEA domain family member 4 isoform 3 |
Synonyms | hCG_27036 TCF13L1 TEF3 RTEF1 |
Description | FUNCTION: Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expression of YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and epithelial mesenchymal transition (EMT) induction. Binds specifically and non-cooperatively to the Sph and GT-IIC 'enhansons' (5'-GTGGAATGT-3') and activates transcription. Binds to the M-CAT motif. . |
Accessions | Q53GI4 H0YGS2 ENST00000358409.7 [Q15561-3] ENST00000359864 A0A0S2Z4F2 H0Y7B0 ENST00000359864.8 [Q15561-1] ENST00000443986.3 H0YG62 ENST00000397122.6 [Q15561-2] A0A0S2Z4E5 H0YFK0 D3DUQ6 ENST00000544666.1 ENST00000543035.6 ENST00000540314.2 Q15561 ENST00000536826.2 H0YFF9 ENST00000358409 A0A0A0MRF3 |